The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Clinical features and long‐term outcome of obesity‐associated focal segmental glomerulosclerosis
Open accessAbstract
BACKGROUND: Several cases of obesity-associated focal segmental glomerulosclerosis (OB-FSG) have been reported but little is known about the clinico-pathological features of this entity and its long-term outcomes. METHODS: We studied 15 obese patients (BMI 35+/-5.2 kg/m(2)) with biopsy-proven FSG. They were compared with a control group of 15 non-obese patients with idiopathic FSG (I-FSG). RESULTS: Mean proteinuria at the time of renal biopsy was 3.1+/-2 g/24 h in OB-FSG; it reached the nephrotic range (> or =3.5 g/24 h) during follow-up in 12 patients (80%), but none of them had oedema, hypoproteinaemia, or hypoalbuminaemia. Proteinuria was more marked amongst I-FSG (6.5+/-4.2 g/24 h) and most of them developed oedema and biochemical nephrotic syndrome. Glomerulomegaly was observed in all renal biopsies from OB-FSG patients (mean glomerular diameter 256+/-24 microm in OB-FSG vs 199+/-26 microm in I-FSG, P<0.001). Twelve OB-FSG patients (80%) were treated with ACE inhibitors (ACEI) and proteinuria significantly decreased within the first 6 months of treatment but showed a later increase. None of the obese patients achieved a sustained weight loss. Seven (46%) patients with OB-FSG experienced a progressive renal insufficiency and five of them started intermittent dialysis. Kaplan-Meier estimated probabilities of renal survival after 5 and 10 years were 77 and 51%, respectively, in OB-FSG patients, and 52 and 30% in I-FSG (P<0.05). The risk of developing progressive renal failure among OB-FSG patients was statistically correlated with serum creatinine and creatinine clearance at presentation. CONCLUSIONS: OB-FSG indicates a poor prognosis with almost one-half of patients developing advanced renal failure. Knowledge of the clinico-pathological features of this entity (obesity, FSG lesions with glomerulomegaly, absence of nephrotic syndrome despite nephrotic-range proteinuria) should be helpful in establishing an accurate and early diagnosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Maschio, G., Alberti, D., Janin, G., Locatelli, F., Mann, J. F. E., Motolese, M., Ponticelli, C., Ritz, E., & Zucchelli, P. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604113341502 · Cited by 1,766
Glomerular hemodynamics in severe obesity
Chagnac, A., Weinstein, T., Korzets, A., Ramadan, E., Hirsch, J., & Gafter, U. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.278.5.f817 · Cited by 614
Praga, M., Hernandez, E., Herrero, J. C., Morales, E., Revilla, Y., Diaz-Gonzalez, R., & Rodicio, J. L. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00384.x · Cited by 354
Self-citationThe Nephrotic Syndrome: A Complication of Massive Obesity
WEISINGER, J. R., KEMPSON, R. L., ELDRIDGE, F. L., & SWENSON, R. S. (1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-81-4-440 · Cited by 318
Frystyk, J., Skjærbæk, C., Vestbo, E., Fisker, S., & Ørskov, H. (1999) · Diabetes/Metabolism Research and Reviews · doi:10.1002/(sici)1520-7560(199909/10)15:5<314::aid-dmrr56>3.0.co;2-e · Cited by 304
The many masks of focal segmental glomerulosclerosis
D'Agati, V. (1994) · Kidney International · doi:10.1038/ki.1994.388 · Cited by 295
Renal Disease in Patients With Massive Obesity
Kasiske, B. L. (1986) · Archives of Internal Medicine · doi:10.1001/archinte.146.6.1105 · Cited by 179
Verani, R. R. (1992) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)70230-5 · Cited by 164
Insulin Resistance, Elevated Glomerular Filtration Fraction, and Renal Injury
Dengel, D. R., Goldberg, A. P., Mayuga, R. S., Kairis, G. M., & Weir, M. R. (1996) · Hypertension · doi:10.1161/01.hyp.28.1.127 · Cited by 161
Effects of Body-Weight Loss and Captopril Treatment on Proteinuria Associated with Obesity
Praga, M., Hernández, E., Andrés, A., León, M., Ruilope, L. M., & Rodicio, J. L. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000188541 · Cited by 148
Self-citationPraga, M., Hernández, E., Montoyo, C., Andrés, A., Ruilope, L. M., & Rodicio, J. L. (1992) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80696-2 · Cited by 132
Self-citationABNORMAL KIDNEY FUNCTION AS A CAUSE AND A CONSEQUENCE OF OBESITY HYPERTENSION
Hall, J. E., Brands, M. W., Henegar, J. R., & Shek, E. W. (1998) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1998.tb02146.x · Cited by 127
Praga, M., Morales, E., Herrero, J. C., et al. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70257-x · Cited by 123
Self-citationGansevoort, R. T., de Zeeuw, D., & de Jong, P. E. (1993) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)70187-7 · Cited by 104
Jennette, J. C., Charles, L., & Grubb, W. (1987) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(87)80196-8 · Cited by 94
Park, Y. S., Guijarro, C., Kim, Y., Massy, Z. A., Kasiske, B. L., Keane, W. F., & Mp, O. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v31.pm9428473 · Cited by 90
Praga, M., Borstein, B., Andres, A. S., Arenas, J., Oliet, A., Montoyo, C., Ruilope, L. M., & Rodicio, J. L. (1991) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80483-5 · Cited by 87
Self-citationGlomerular hemodynamic alterations during acute hyperinsulinemia in normal and diabetic rats
Tucker, B. J., Anderson, C. M., Thies, R. S., Collins, R. C., & Blantz, R. C. (1992) · Kidney International · doi:10.1038/ki.1992.400 · Cited by 87
Massive Obesity and Nephrotic Proteinuria with a Normal Renal Biopsy
Wesson, D. E., Kurtzman, N. A., & Frommer, P. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000183467 · Cited by 65
Reflux Nephropathy and Primary Vesicoureteric Reflux in Adults
El-Khatib, M. T., Becker, G. J., & Kincaid‐Smith, P. (1990) · QJM · doi:10.1093/qjmed/77.3.1241 · Cited by 55
Reversible Proteinuria in Obstructive Sleep Apnea Syndrome
Sklar, A. H. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380010091009 · Cited by 53
Warnke, R. A., & Kempson, R. L. (1978) · PubMed · Cited by 51
Guijarro, C., & Keane, W. F. (1996) · PubMed · Cited by 38
Bailey, R. R., Burry, A. F., Lynn, K. L., & Drennan, C. (1989) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1989.tb00310.x · Cited by 34
Cited by
Glomerular number and size in autopsy kidneys: The relationship to birth weight
Hughson, M., Farris, A. B., Douglas-Denton, R., Hoy, W. E., & Bertram, J. F. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00018.x · Cited by 760
Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis
D'Agati, V. D., Chagnac, A., de Vries, A. P. J., Levi, M., Porrini, E., Herman-Edelstein, M., & Praga, M. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.75 · Cited by 716
Self-citationMechanisms of obesity-induced hypertension
Kotsis, V., Stabouli, S., Papakatsika, S., Rizos, Z., & Parati, G. (2010) · Hypertension Research · doi:10.1038/hr.2010.9 · Cited by 627
Kopp, J. B., Anders, H.-J., Susztak, K., Podestà, M. A., Remuzzi, G., Hildebrandt, F., & Romagnani, P. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0196-7 · Cited by 562
Obesity and Obesity-Initiated Metabolic Syndrome: Mechanistic Links to Chronic Kidney Disease
Wahba, I. M., & Mak, R. H. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04071206 · Cited by 513
Metadata
- Authors
- Praga, M., Hernández, E., Morales, E., Campos, A. P., Valero, M. A., Martínez, M. A., & León, M.
- Venue
- Nephrology Dialysis Transplantation
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-09-01
- Volume
- 16
- Issue
- 9
- Pages
- 1790-1798
- ISSN
- 0931-0509 (ISSN-L)
- 1460-2385
- OpenAlex
- W2115694679
- Cited by
- 287
- References
- 25
- FWCI
- 3.58
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.